Q4 2018 13F Holders as of 12/31/2018
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
101M
-
Number of holders
-
189
-
Total 13F shares, excl. options
-
56.5M
-
Shares change
-
-996K
-
Total reported value, excl. options
-
$2.62B
-
Value change
-
-$105M
-
Put/Call ratio
-
0.95
-
Number of buys
-
110
-
Number of sells
-
-69
-
Price
-
$46.28
Significant Holders of FIBROGEN INC - Common Stock, $0.01 par value (FGEN) as of Q4 2018
237 filings reported holding FGEN - FIBROGEN INC - Common Stock, $0.01 par value as of Q4 2018.
FIBROGEN INC - Common Stock, $0.01 par value (FGEN) has 189 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 56.5M shares
of 101M outstanding shares and own 56% of the company stock.
Largest 10 shareholders include FMR LLC (9.76M shares), Vanguard Group Inc (7.14M shares), BlackRock Inc. (6.31M shares), STATE STREET CORP (2.66M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.28M shares), Hillhouse Capital Advisors, Ltd. (2M shares), JANUS HENDERSON GROUP PLC (1.74M shares), FIRST TRUST ADVISORS LP (1.71M shares), EcoR1 Capital, LLC (1.52M shares), and JPMORGAN CHASE & CO (1.2M shares).
This table shows the top 189 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.